Benefits of short-Term professional continuous glucose monitoring in clinical practice

Diabetes Technology and Therapeutics

Volumn 15, Issue 9, 2013, Pages 744-747

  Leinung, Matthew ^a   Nardacci, Elizabeth ^a   Patel, Nilem ^a   Bettadahalli, Shankar ^a   Paika, Khisar ^a   Thompson, Shannon ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL PRACTICE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SELF REPORT; AGED; ANALYSIS; BLOOD; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; MIDDLE AGED; PHYSIOLOGIC MONITORING; PROCEDURES; RETROSPECTIVE STUDY;

ADULT; AGED; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; RETROSPECTIVE STUDIES;

EID: 84883320518     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2013.0027     Document Type: Article

References (8)

1. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Hirsch IB, Huang ES, Kollman C, Kowalski AJ, Laffel L, Lawrence JM, Lee J, Mauras N, O'Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer S, Wilson DM, Wolpert H, Wysocki T, Xing D: Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008;359:1464-1476.
2. Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, Joyce C, Peoples T, Perkins BA, Welsh JB, Willi SM, Wood MA; STAR 3 Study Group: Effectiveness of sensoraugmented insulin-pump therapy in type 1 diabetes. N Engl J Med 2010;363:311-320.
3. Leinung M, Thompson S, Nardacci E: Benefits of continuous glucose monitor use in clinical practice. Endocr Pract 2010; 16:371-375.
4. Pepper GM, Steinsapir J, Reynolds K: Effect of short term iPro continuous glucose monitoring on hemoglobin A1c levels in clinical practice. Diabetes Technol Ther 2012;14:1-4.
5. Patel N, Bettadahalli S, Paika K, Nardacci E, Thompson S, Leinung M: Clinical utility of office-based continuous glucose monitoring in the care of patients with uncontrolled diabetes [abstract]. Endocr Rev 2010;31(3 Suppl 1):S1454.
6. Xing D, Kollman C, Beck RW, Tamborlane WV, Laffel L, Buckingham BA, Wilson DM, Weinzimer S, Fiallo-Scharer R, Ruedy KJ; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group: Optimal sampling intervals to assess long-Term glycemic control using continuous glucose monitoring. Diabetes Technol Ther 2011;13: 351-358.
7. Vigersky R, Fonda SJ, Chellappa M, Walker SM, Ehrhardt NM: Short- and long-Term effects of real-Time continuous glucose monitoring in patients with type 2 diabetes. Diabetes Care 2012;35:32-38.
8. Rodbard D, Jovanovic L, Garg SK: Responses to continuous glucose monitoring in subjects with type 1 diabetes using continuous subcutaneous insulin infusion or multiple daily injections. Diabetes Technol Ther 2009;11:757-765